251 related articles for article (PubMed ID: 32633635)
21. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia.
Tan TK; Zhang C; Sanda T
Int J Hematol; 2019 Jan; 109(1):5-17. PubMed ID: 30145780
[TBL] [Abstract][Full Text] [Related]
22. TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia.
Thielemans N; Demeyer S; Mentens N; Gielen O; Provost S; Cools J
Haematologica; 2022 Oct; 107(10):2304-2317. PubMed ID: 35354248
[TBL] [Abstract][Full Text] [Related]
23. Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth.
Sharma A; Mistriel-Zerbib S; Najar RA; Engal E; Bentata M; Taqatqa N; Dahan S; Cohen K; Jaffe-Herman S; Geminder O; Baker M; Nevo Y; Plaschkes I; Kay G; Drier Y; Berger M; Salton M
PLoS Biol; 2023 Jun; 21(6):e3002175. PubMed ID: 37379322
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-204 inhibits cell proliferation in T-cell acute lymphoblastic leukemia by down-regulating SOX4.
Yin JJ; Liang B; Zhan XR
Int J Clin Exp Pathol; 2015; 8(8):9189-95. PubMed ID: 26464665
[TBL] [Abstract][Full Text] [Related]
25. Targeting dual oncogenic machineries driven by TAL1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia.
Lim FQ; Chan AS; Yokomori R; Huang XZ; Theardy MS; Yeoh AEJ; Tan SH; Sanda T
Haematologica; 2023 Feb; 108(2):367-381. PubMed ID: 36073513
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.
Qian L; Zhang W; Lei B; He A; Ye L; Li X; Dong X
Oncol Rep; 2016 Nov; 36(5):2511-2516. PubMed ID: 27666896
[TBL] [Abstract][Full Text] [Related]
27. MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.
Astolfi A; Vendemini F; Urbini M; Melchionda F; Masetti R; Franzoni M; Libri V; Serravalle S; Togni M; Paone G; Montemurro L; Bressanin D; Chiarini F; Martelli AM; Tonelli R; Pession A
Oncotarget; 2014 Jan; 5(1):120-30. PubMed ID: 24334727
[TBL] [Abstract][Full Text] [Related]
28. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
[TBL] [Abstract][Full Text] [Related]
29. A novel TAL1/miR-149* axis accelerates tumor growth of human T cell acute lymphoblastic leukemia.
Zhao Y; Li H; Li Y; Chen X; Fan S
Int J Clin Exp Pathol; 2018; 11(8):4026-4034. PubMed ID: 31949792
[No Abstract] [Full Text] [Related]
30. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression.
Haider Z; Larsson P; Landfors M; Köhn L; Schmiegelow K; Flaegstad T; Kanerva J; Heyman M; Hultdin M; Degerman S
Cancer Med; 2019 Jan; 8(1):311-324. PubMed ID: 30575306
[TBL] [Abstract][Full Text] [Related]
31. TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Tan SH; Tan TK; Yokomori R; Liao M; Huang XZ; Yeoh AEJ; Sanda T
Leukemia; 2023 Oct; 37(10):1969-1981. PubMed ID: 37591943
[TBL] [Abstract][Full Text] [Related]
32. Novel TAL1 targets beyond protein-coding genes: identification of TAL1-regulated microRNAs in T-cell acute lymphoblastic leukemia.
Correia NC; Durinck K; Leite AP; Ongenaert M; Rondou P; Speleman F; Enguita FJ; Barata JT
Leukemia; 2013 Jul; 27(7):1603-6. PubMed ID: 23448994
[No Abstract] [Full Text] [Related]
33. Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia.
Oliveira LH; Schiavinato JL; Fráguas MS; Lucena-Araujo AR; Haddad R; Araújo AG; Dalmazzo LF; Rego EM; Covas DT; Zago MA; Panepucci RA
Cancer Sci; 2015 Oct; 106(10):1264-77. PubMed ID: 26251039
[TBL] [Abstract][Full Text] [Related]
34. ARRB1-Promoted NOTCH1 Degradation Is Suppressed by OncomiR miR-223 in T-cell Acute Lymphoblastic Leukemia.
Shu Y; Wang Y; Lv WQ; Peng DY; Li J; Zhang H; Jiang GJ; Yang BJ; Liu S; Zhang J; Chen YH; Tang S; Wan KX; Yuan JT; Guo W; Fu G; Qi XK; Liu ZD; Liu HY; Yang C; Zhang LH; Liu FJ; Yu J; Zhang PH; Qu B; Zhao H; He TC; Zou L
Cancer Res; 2020 Mar; 80(5):988-998. PubMed ID: 31822496
[TBL] [Abstract][Full Text] [Related]
35. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.
Leong WZ; Tan SH; Ngoc PCT; Amanda S; Yam AWY; Liau WS; Gong Z; Lawton LN; Tenen DG; Sanda T
Genes Dev; 2017 Dec; 31(23-24):2343-2360. PubMed ID: 29326336
[TBL] [Abstract][Full Text] [Related]
36. Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line.
Podshivalova K; Wang EA; Hart T; Salomon DR
Leuk Res; 2018 Nov; 74():1-9. PubMed ID: 30269036
[TBL] [Abstract][Full Text] [Related]
37. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
[TBL] [Abstract][Full Text] [Related]
38. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia.
Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349
[TBL] [Abstract][Full Text] [Related]
39. Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.
Kumar V; Palermo R; Talora C; Campese AF; Checquolo S; Bellavia D; Tottone L; Testa G; Miele E; Indraccolo S; Amadori A; Ferretti E; Gulino A; Vacca A; Screpanti I
Leukemia; 2014 Dec; 28(12):2324-35. PubMed ID: 24727676
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Investigation of miRNome Identifies Novel Candidate miRNA-mRNA Interactions Implicated in T-Cell Acute Lymphoblastic Leukemia.
Dawidowska M; Jaksik R; Drobna M; Szarzyńska-Zawadzka B; Kosmalska M; Sędek Ł; Machowska L; Lalik A; Lejman M; Ussowicz M; Kałwak K; Kowalczyk JR; Szczepański T; Witt M
Neoplasia; 2019 Mar; 21(3):294-310. PubMed ID: 30763910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
